|
Market Closed -
OTC Markets
09:31:56 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | - |
| 25-08-26 | MegaGen Implant Co., Ltd. acquired All Assets of BIOLASE, Inc from BIOLASE, Inc. (OTCPK:BIOL.Q). | CI |
| 25-05-19 | EnVVeno Medical Names Jennifer Bright CFO | MT |
Chart calendar BIOLASE, Inc.
91b49799d7d8bb632e8fdfe93ed6779d.n8XIjQAQUOXn9PdnhYVi0jAuDg6ucXbky6e6nvlyYZ8.1aqi2HUkJq2euJEpy_8G5UdNQEXbBwaH-P3pxq5LVP3L8Y7rSikZ1auGtg~82780b10a53d620ba0f2bda0d529658a
Upcoming events on BIOLASE, Inc.
No events available
Past events on BIOLASE, Inc.
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 39,2 38,7 1.15% | 48,5 48,5 -0.02% | 49,2 48,9 0.62% |
|
EBITDA Million USD | Released Forecast Spread | -14,7 -12,9 -13.64% | -20,1 -16,7 -20.59% | -12,8 -12,5 -2.6% |
|
EBIT Million USD | Released Forecast Spread | -16,4 -15,3 -7.71% | -25,3 -20,6 -22.9% | -17,9 -16,7 -7.19% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,1 -14,9 -8.18% | -28,5 -23,0 -24.23% | -20,6 -19,5 -5.68% |
|
Net income Million USD | Released Forecast Spread | -16,7 -15,2 -9.65% | -28,9 -23,1 -24.92% | -37,6 -19,6 -92.17% |
|
EPS USD | Released Forecast Spread | -275 -263 -4.76% | -416 -345 -20.46% | -29,4 -26,4 -11.68% |
| Announcement Date | 17/03/22 | 28/03/23 | 21/03/24 |
Quarterly results
| Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 10,5 10,2 2.84% | 14,3 15,4 -6.97% | 10,9 13,2 -17.33% | 13,5 13,2 2.01% | 10,1 10,00 1.35% | 11,6 13,5 -14.38% |
|
EBITDA Million USD | Released Forecast Spread | -4,45 -2,90 -53.38% | -2,31 -1,77 -30.81% | -3,15 -1,75 -79.94% | -2,86 -2,55 -12.31% | -3,53 -2,45 -44.08% | -2,55 -0,65 -291.54% |
|
EBIT Million USD | Released Forecast Spread | -5,29 -4,56 -16.06% | -3,87 -2,76 -40.21% | -3,70 -2,41 -53.42% | -5,08 -3,91 -29.71% | -4,53 -3,68 -22.92% | -3,22 -1,61 -99.59% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,85 -5,15 -13.48% | -4,84 -3,21 -50.8% | -4,57 -2,86 -60.18% | -5,34 -4,31 -23.99% | -6,47 -4,03 -60.54% | -2,78 -2,21 -25.68% |
|
Net income Million USD | Released Forecast Spread | -5,85 -5,15 -13.5% | -4,87 -3,21 -51.77% | -4,59 -2,86 -60.71% | -5,33 -4,31 -23.64% | -6,49 -4,03 -61.01% | -2,80 -2,21 -26.59% |
|
EPS USD | Released Forecast Spread | -18,0 -19,7 8.47% | -8,93 -5,33 -67.44% | -3,89 -1,85 -110.27% | -1,76 -2,56 31.12% | -0,36 -0,17 -111.76% | -0,08 -0,08 -6.67% |
| Announcement Date | 11/05/23 | 10/08/23 | 09/11/23 | 21/03/24 | 13/05/24 | 08/08/24 |
| 2026-11-01 |  | Extraordinary General Meeting | |
| 2026-11-02 | | Présentation aux Actionnaires / Analystes | 09:00 |
| 2027-03-23 | | Earnings release - Annual 2026 | |
| 2027-08-19 | | Earnings release - Q2 2027 |
Past sector events for BIOLASE, Inc.
| 2026-08-19 | | Earnings release - Q2 2026 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BIOLQ Stock
- Calendar BIOLASE, Inc.
Select your edition
All financial news and data tailored to specific country editions
